Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing ...
Key recent performance and business profile Biogen (BIIB) has moved quietly higher, with the share price showing a 0.8% decline over the last day but gains of 1.5% over the past week and 18.1% over ...
Investor's Business Daily on MSN
This rare disease biotech name teases around a buy point
This company develops treatments for rare genetic diseases. It partners with Biogen.
Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Its products include TECFIDERA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results